Skip to content

BIO

Bio-Rad Laboratories, Inc.

Stock

$369.14+13.57 (+3.82%)Close Oct 2, 2026

Balance sheet

LineQ2 2026202520242023202220212020201920182017201620152014201320122011201020092008
Cash and short-term investments$1.6B$1.5B$1.7B$1.6B$1.8B$870M$991M$1.1B$845M$755M$839M$786M$698M$609M$921M$813M$1.0B$745M$205M
Inventory$781M$741M$760M$781M$719M$572M$622M$554M$584M$595M$525M$490M$471M$516M$455M$434M$398M$351M—
Current assets$3.0B$2.9B$3.0B$3.0B$3.2B$2.0B$2.1B$2.2B$2.0B$2.0B$1.8B$1.8B$1.7B$1.8B$1.9B$1.8B$2.0B$1.6B—
Goodwill$574M$580M$411M$414M$406M$347M$292M$264M$220M$506M$477M$496M$500M$518M$495M$469M$364M$328M—
Intangible assets$160M$174M$294M$321M$332M$254M$199M$146M$133M$174M$162M$214M$254M$266M$261M$259M$204M$205M—
Total assets$10.3B$10.6B$9.4B$12.3B$13.5B$17.8B$13.0B$8.0B$5.6B$4.3B$3.9B$3.7B$3.3B$3.4B$3.4B$3.1B$3.1B$2.5B—
Current liabilities$961M$517M$468M$523M$569M$681M$632M$905M$451M$503M$471M$441M$447M$487M$472M$459M$667M$420M—
Long-term debt$803M$1.2B$1.2B$1.2B$1.2B$11M$12M$14M$439M$435M$434M$434M$436M$436M$732M$732M$731M$738M—
Total liabilities$3.1B$3.1B$2.8B$3.6B$3.9B$4.1B$3.1B$2.3B$1.6B$1.3B$1.3B$1.2B$1.2B$1.2B$1.4B$1.4B$1.5B$1.3B—
Shareholders' equity$7.2B$7.5B$6.6B$8.7B$9.6B$13.7B$9.9B$5.8B$4.0B$2.9B$2.6B$2.5B$2.2B$2.2B$2.0B$1.7B$1.5B$1.3B$1.1B
Current ratio3.145.626.485.835.552.923.392.414.493.933.914.033.843.614.103.922.963.72—